Pulmonology

The application, submitted by Merck, is based on data from 2 clinical trials evaluating patients with refractory or unexplained chronic cough.

From better education, to remote monitoring and consistent check-ins, clinicians may need to initiate better adherence in their younger, severely ill patients.

An interview on the TSLP inhibitor's effect on exacerbations, hospitalizations, and disease progress over 52-week findings.

Oxygen saturation levels similar for both asthma patients and non-asthma patients following mask use.

MYMD-1 targets the root cause of inflammation for patients with IPF.

New survey results depict unexpected burdens in long-haul patients, as well as continued issues following rehabilitation.

Common positive effects includes help with sleep, less pain, and calming influence.

An interview with a study author on new interpretations of biologic asthma benefit.

Treatment showed a similar effect on patients with and without baseline asthma.

Researchers explore further endpoints from the SINUS-24 and SINUS-52 trials.

In data presented at AAAAI 2021, researchers present new data from the LIBERTY ASTHMA QUEST trial.

New research show the novel DNRI benefits patients both adherent and not to their OSA primary therapy.

Partnerships between primary care physicians and pulmonologists may improve vaccination rates for patients with COPD.

The monoclonal antibody may provide a novel treatment pathway for the chronic, often deadly pulmonary disease.

The co-lead investigators discuss the upcoming first study to assess long-term outcomes on MIS-C patients.

A cohort assessment shows a 57% increased risk of pediatric asthma development among children given PPIs to treat gastrointestinal tract disorders.

A conversation with an expert virologist and public health advocate on the scientific and societal machinations of COVID-19 vaccination.

Patients receiving the drug experienced improvement in the 6-minute walk test and demonstrated a lower risk of clinical worsening.

Anne Dixon, MD, explains how it took 6 years to update recommendations for new asthma therapies.

Increased cumulative smoking was associated with increased risk of hospitalization and death.

More than two-thirds of smokers want to quit, but lack proper resources. A prescribing professional could help make up that difference.

The study underscores the importance of lowering air pollution concentrations below WHO guidelines.

A conversation on how associations between the chronic conditions have become better understood in 10 years.

A discussion around obesity's effect on asthma, and the newest recommendations for managed care.

To combat the deadliest cancer in the world, investigators are learning its origin in at-risk patients to prevent it altogether.